Qantas Airways downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded Qantas Airways (QABSY) to Neutral from Outperform with a price target of A$9.30, up from A$8.40. Qantas ...
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform ...
Landstar: Lacklustre Q4 And FY Results Fail To Compromise Long-Term Potential
Landstar Systems remains profitable despite revenue challenges, with a strong balance sheet and undervalued stock - a ...
AMD: Playing Second Fiddle To Nvidia Is No Fun (Downgrade)
AMD's cautious outlook and Nvidia's strong position in the AI market as the tech giants focus on AI CapEx investments in 2025 ...